State Street’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$562M Sell
4,468,266
-393,850
-8% -$49.5M 0.02% 517
2025
Q1
$538M Sell
4,862,116
-29,021
-0.6% -$3.21M 0.02% 516
2024
Q4
$668M Sell
4,891,137
-257,156
-5% -$35.1M 0.03% 479
2024
Q3
$593M Buy
5,148,293
+539,936
+12% +$62.2M 0.02% 510
2024
Q2
$634M Buy
4,608,357
+618,396
+15% +$85.1M 0.03% 468
2024
Q1
$550M Sell
3,989,961
-73,375
-2% -$10.1M 0.02% 503
2023
Q4
$535M Buy
4,063,336
+226,829
+6% +$29.9M 0.03% 502
2023
Q3
$432M Sell
3,836,507
-119,992
-3% -$13.5M 0.02% 516
2023
Q2
$373M Buy
3,956,499
+156,584
+4% +$14.8M 0.02% 568
2023
Q1
$385M Buy
3,799,915
+69,729
+2% +$7.06M 0.02% 559
2022
Q4
$446M Sell
3,730,186
-36,535
-1% -$4.36M 0.03% 510
2022
Q3
$400M Sell
3,766,721
-5,939
-0.2% -$631K 0.03% 524
2022
Q2
$368M Buy
3,772,660
+38,490
+1% +$3.75M 0.02% 560
2022
Q1
$350M Buy
3,734,170
+7,029
+0.2% +$659K 0.02% 631
2021
Q4
$317M Buy
3,727,141
+266,073
+8% +$22.7M 0.02% 661
2021
Q3
$332M Buy
3,461,068
+47,735
+1% +$4.58M 0.02% 636
2021
Q2
$332M Buy
3,413,333
+145,990
+4% +$14.2M 0.02% 653
2021
Q1
$318M Buy
3,267,343
+790,012
+32% +$76.8M 0.02% 629
2020
Q4
$237M Buy
2,477,331
+199,942
+9% +$19.2M 0.01% 693
2020
Q3
$219M Sell
2,277,389
-10,651
-0.5% -$1.02M 0.02% 654
2020
Q2
$279M Sell
2,288,040
-223,221
-9% -$27.2M 0.02% 574
2020
Q1
$217M Buy
2,511,261
+57,653
+2% +$4.99M 0.02% 581
2019
Q4
$264M Buy
2,453,608
+626,052
+34% +$67.3M 0.02% 624
2019
Q3
$165M Sell
1,827,556
-27,875
-2% -$2.51M 0.01% 753
2019
Q2
$157M Sell
1,855,431
-162,723
-8% -$13.7M 0.01% 778
2019
Q1
$178M Buy
2,018,154
+177,309
+10% +$15.6M 0.01% 717
2018
Q4
$131M Buy
1,840,845
+172,376
+10% +$12.3M 0.01% 770
2018
Q3
$205M Sell
1,668,469
-105,598
-6% -$13M 0.02% 702
2018
Q2
$174M Sell
1,774,067
-149,001
-8% -$14.6M 0.01% 743
2018
Q1
$159M Sell
1,923,068
-68,109
-3% -$5.65M 0.01% 775
2017
Q4
$154M Sell
1,991,177
-468,662
-19% -$36.4M 0.01% 789
2017
Q3
$151M Sell
2,459,839
-250,357
-9% -$15.3M 0.01% 772
2017
Q2
$125M Buy
2,710,196
+131,141
+5% +$6.03M 0.01% 842
2017
Q1
$112M Buy
2,579,055
+289,884
+13% +$12.6M 0.01% 879
2016
Q4
$88.6M Buy
2,289,171
+145,703
+7% +$5.64M 0.01% 967
2016
Q3
$109M Buy
2,143,468
+227,066
+12% +$11.5M 0.01% 823
2016
Q2
$87.1M Sell
1,916,402
-765,662
-29% -$34.8M 0.01% 902
2016
Q1
$106M Buy
2,682,064
+499,687
+23% +$19.8M 0.01% 816
2015
Q4
$123M Buy
2,182,377
+162,984
+8% +$9.22M 0.01% 751
2015
Q3
$80.4M Sell
2,019,393
-19,904
-1% -$792K 0.01% 915
2015
Q2
$97.4M Buy
2,039,297
+42,558
+2% +$2.03M 0.01% 888
2015
Q1
$79.3M Sell
1,996,739
-90,955
-4% -$3.61M 0.01% 988
2014
Q4
$46.6M Sell
2,087,694
-127,440
-6% -$2.85M ﹤0.01% 1263
2014
Q3
$34.7M Buy
2,215,134
+43,254
+2% +$678K ﹤0.01% 1370
2014
Q2
$32.2M Sell
2,171,880
-71,769
-3% -$1.07M ﹤0.01% 1475
2014
Q1
$36.1M Sell
2,243,649
-504,516
-18% -$8.12M ﹤0.01% 1390
2013
Q4
$25.7M Sell
2,748,165
-69,843
-2% -$652K ﹤0.01% 1577
2013
Q3
$31.9M Buy
2,818,008
+792,090
+39% +$8.97M ﹤0.01% 1418
2013
Q2
$27.1M Buy
+2,025,918
New +$27.1M ﹤0.01% 1449